PAYVANDI, FLORA
PAYVANDI, FLORA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
2025 O. Seidizadeh, L. Mollica, D. Giana, L. Baronciani, P. Colpani, L. Sicuro, A. Cairo, F. Peyvandi
Global prevalence of platelet-type von Willebrand disease
2025 O. Seidizadeh, A. Cairo, M. Othman, F. Peyvandi
Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study
2025 L.P. Solimeno, R. Gualtierotti, E. Guido, J. Acquati Lozej, E. Cristini, A. Ciavarella, S. Arcudi, C. Carulli, L. Pieri, S.M. Siboni, F. Peyvandi
Gene therapy in hemophilia: the dawn of a new era
2025 R. Gualtierotti, A. Giachi, N. Bitto, V. La Mura, F. Peyvandi
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
2025 P. Agosti, I. Mancini, A. Artoni, C. Cardone, P. De Leo, C. Bichard, A. Truma, B. Ferrari, J.A. Giannotta, N.N. Fantini, M.C. Mocellin, D. Prati, F. Peyvandi
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
2025 K. Fischer, R. Lassila, F. Peyvandi, A. Gatt, S.C. Gouw, R. Hollingsworth, T. Lambert, R. Kaczmarek, D.C. Alvarez, M. Makris
Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance
2025 E. Scalambrino, M. Clerici, F. Peyvandi, A. Tripodi
Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
2025 H. Chand, S. Hassan, A. Cairo, R. Palla, F. Peyvandi, F. Peyvandi, P.M. Mannucci, I. Garagiola, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, S. Hanagavadi, R. Varadarajan, M. Karimi, M.V. Manglani, C. Ross, G. Young, T. Seth, S. Apte, D.M. Nayak, E. Santagostino, M.E. Mancuso, A.C. Sandoval Gonzalez, J.N. Mahlangu, S. Bonanad Boix, M. Cerqueira, N.P. Ewing, C. Male, T. Owaidah, V. Soto Arellano, N.L. Kobrinsky, S. Majumdar, R.P. Garrido, A. Sachdeva, M. Simpson, M. Thomas, E. Zanon, B. Antmen, K. Kavakli, M.J. Manco-Johnson, M. Martinez, E. Marzouka, M.G. Mazzucconi, D. Neme, A. Palomo Bravo, R. Paredes Aguilera, A. Prezotti, K. Schmitt, B.M. Wicklund, B. Zulfikar, F.R. Rosendaal
Clarifying the role of p.Gln723Lys in hTTP prevalence
2025 O. Seidizadeh, A. Cairo, I. Mancini, J.N. George, F. Peyvandi
Challenges and considerations of genetic testing in von Willebrand disease
2025 O. Seidizadeh, L. Baronciani, F. Peyvandi
Genome-wide association study of long COVID
2025 V. Lammi, T. Nakanishi, S.E. Jones, S.J. Andrews, J. Karjalainen, B. Cortes, H.E. O'Brien, A. Ochoa-Guzman, B.E. Fulton-Howard, M. Broberg, H.H. Haapaniemi, M. Kanai, M. Pirinen, A. Schmidt, R.E. Mitchell, A. Mousas, M. Mangino, A. Huerta-Chagoya, N. Sinnott-Armstrong, E.T. Cirulli, M. Vaudel, A.S.F. Kwong, A.K. Maiti, M.M. Marttila, D.C. Posner, A.A. Rodriguez, C. Batini, F. Minnai, A.R. Dearman, C.A.R. Warmerdam, C.B. Sequeros, T.W. Winkler, D.M. Jordan, R. Rescenko, L. Miano, J.M. Lane, R.K. Chung, B. Guillen-Guio, O.C. Leavy, L. Carvajal-Silva, K. Aguilar-Valdes, E. Frangione, L. Guare, E. Vergasova, E. Marouli, P. Striano, U.A. Zainulabid, A. Kumar, H.F. Ahmad, R. Edahiro, S. Azekawa, C. Maj, M.C. Pensel, A. Miller, M.M. Nothen, P. Behzad, S. Schultz, J. Heggemann, D. Balla, D.R. Morrison, V. Mooser, D. Perley, J. Ragoussis, S. Rousseau, F. Shi, G.M. Lathrop, S. Yanishevsky, L. Laurent, D. Auld, M. Bertrand, A. Boisclair, G. Bourque, D. Bujold, M. Durand, D. Adra, J. St-Cyr, M.E.K. Niemi, S.K. Iyengar, T. Cai, K. Cho, S. Sarvadhavabhatla, M.S. Donaire, H. Valenzuela-Jorquera, E. Lamoza, T.V. Arevalo, R. Retamales-Ortega, S. Sanhueza, C.S. Selman, A.X. Silva, T.A. Alarcon, M.F. Martinez, R. Quiroga, P. Zuniga-Pacheco, D. Zapata-Contreras, C.E. Yanez, L.A. Quinones, E.A. Tobar-Calfucoy, V.A. Monardes-Ramirez, I.A. Signore, L.G. Guajardo, A. Figueroa, K.Y. Orostica, C.A. Munoz, M. Fuentes-Guajardo, P. Bocchieri, C. Cabrera, C.A. Echeverria, L.C. Cerpa, G. Donoso, S. Gutierrez-Richards, E. Nova-Lamperti, J.M. Saez Hidalgo, Y. Espinosa-Parrilla, B. Hignell, V. Forgetta, N.R. Harvey, J. Erber, M. Budde, U. Heilbronner, I.-. Larsson, L. Fricke, M. Lipcsey, K. Adorjan, T. Maricic, J.L. Kalman, A. Dinkel, N.S. Mueller, M. Cordioli, U. Protzer, C.D. Spinner, F. Senner, R. Frithiof, E. Wallin, C. Winter, T.G. Schulze, J. Schneider, J. Wiltfang, S. Papiol, C.M. Kripke, A. Verma, M.D. Ritchie, D.J. Rader, L. Trogstad, M. Duran-Gomez, P. Pajukanta, H. Moreno-Macias, S.H.T. Lee, C.A. Aguilar Salinas, G. Castano-Vinyals, M. Kogevinas, X. Farre, A. Carreras, C. Dobano, N. Blay, J. Garcia-Aymerich, A. Blasco, G. Moncunill, S. Iraola-Guzman, R. De Cid, A.L. Guyatt, A.S.B. Mortensen, B. Feenstra, D. Westergaard, S. Brunak, S.R. Ostrowski, N.W. Simons, L.G. Sloofman, A.W. Charney, R.C. Thompson, H. Namkoong, A. Amirsavadkouhi, H.A. Tadi, B. Sharififard, N. Soltani, V. Zarei, R. Aliannejad, E. Ntzani, E. Evangelou, A. Liontos, I. Tzoulaki, H. Milionis, E. Christaki, K.M. Schiabor Barrett, A. Bolze, S. Dabe, I. Neveux, S. White, N.L. Washington, E. Sandoval, F. Tanudjaja, A. Kamelin, V. Ilinsky, D. Kharitonov, A. Kim, N. Plotnikov, L. Shaheen, M. Trofimov, A. Ilinskaya, T. Hannah, F. Colombo, M. Baldassarri, K. Zguro, C. Fallerini, S. Furini, M. Maher, J.M. Cherry, A.C. Burns, R. Saxena, J. Klovins, M. Briviba, P. Raitis, V. Rovite, L.T. Elliott, J. Taher, X. Xinyi, O. Vishnyakova, T.H. Karlsen, F.B.A. Blasi, F. Blandini, A. Bandera, F. Degenhardt, A. Nobili, N. Montano, N. Iannotti, D. Ellinghaus, A. Franke, M. Mantero, G. Lamorte, F. Malvestiti, S. Margarita, A. Muscatello, R. Carpani, F. Peyvandi, D. Prati, L. Ronzoni, M. Tettamanti, A. Kukkonen, S.-. Luoh, C. Erikstrup, O.B.V. Pedersen, J. Lerner-Ellis, A. Colombo, J.J. Grzymski, M. Ishii, Y. Okada, N.D. Beckmann, M. Kumari, R. Wagner, I.M. Heid, C. John, P.J. Short, P. Magnus, L. Ansone, L.V.C. Valenti, S.A. Lee, L.V. Wain, R.A. Verdugo, K. Banasik, F. Geller, L.H. Franke, A. Rakitko, E.L. Duncan, A. Renieri, K.K. Tsilidis, R. De Cid, A. Niavarani, E. Abner, T. Tusie-Luna, S.S. Verma, G.D. Smith, N.J. Timpson, R.K. Madduri, M.J. Daly, A. Ganna, E.C. Schulte, J.B. Richards, K.U. Ludwig, M. Marks-Hultstrom, H. Zeberg, H.M. Ollila
The genetic spectrum of rare bleeding disorders
2025 S. Mohsenian, O. Seidizadeh, A. Cairo, R. Palla, M. Menegatti, F. Peyvandi
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in France
2025 C. Auditeau, C. Valsecchi, N.K. Bentounes, A. Le-Goff, A. Harroche, C. Bally, P.J. Lenting, D. Borgel, F. Peyvandi, D. Lasne
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII
2025 R. Lombardi, R. Forlano, G. Maffi, A. Cespiati, F. Cinque, D. Bignamini, P. Dongiovanni, P. Francione, G. Sigon, J. Huang, P. Manousou, F. Peyvandi, A. Tripodi, A.L. Fracanzani
The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
2025 M. Abbattista, A. Truma, I. Martinelli, F. Gianniello, S.M. Passamonti, M. Capecchi, A. Artoni, F. Peyvandi, P. Bucciarelli
Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A
2025 A. Gringeri, P.M. Mannucci, M. Gringeri, G. Castaman, F. Peyvandi
AAV Gene Therapy in Severe Hemophilia B
2025 W. Miesbach, F. Peyvandi, G. Pierce
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study
2025 J.A. Giannotta, A. Artoni, I. Mancini, P. Agosti, M. Carpenedo, A. Truma, S. Miri, B. Ferrari, P. De Leo, P. Salutari, G. Mancini, A. Molteni, E. Rinaldi, M. Bocchia, M. Napolitano, L. Prezioso, A. Cuccaro, E. Scarpa, A. Condorelli, D. Grimaldi, M. Massaia, F. Peyvandi
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
2025 W. Miesbach, P. Batty, P. Chowdary, S. Fong, R. Kaczmarek, F.W.G. Leebeek, B. Long, J. Mahlangu, M. Makris, G.F. Pierce, S.W. Pipe, A. Srivastava, J. Voorberg, F. Peyvandi